Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 1,725 | 906 | 1,602 | 373 | 387 |
| Operating Income | -1,725 | -906 | -1,602 | -373 | -387 |
| Interest Expense | 2 | 4 | 0 | 0 | 0 |
| Other Income | 0 | 3 | 0 | 0 | 4 |
| Pre-tax Income | -1,727 | -907 | -1,602 | -373 | -383 |
| Net Income Continuous | -1,727 | -907 | -1,602 | -373 | -383 |
| Net Income | $-1,727 | $-907 | $-1,602 | $-373 | $-383 |
| EPS Basic Total Ops | -1.40 | -0.90 | -1.40 | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -1.35 | -0.79 | -1.43 | -0.33 | -0.34 |
| EPS Diluted Total Ops | -1.40 | -0.90 | -1.40 | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -1.35 | -0.79 | -1.43 | -0.33 | -0.34 |
| EBITDA(a) | $-1,725 | $-906 | $-1,602 | $-373 | $-387 |